Madame Monica Geingos

Monica Geingos is a qualified lawyer with extensive corporate experience. Before assuming the First Lady role in 2015, she was a co-shareholder and Managing Director of Namibia’s largest private equity fund for over a decade served on the Boards of large public and private sector companies as either Chairperson or Deputy Chairperson. Mrs. Geingos was […]
Chris Canavan

Chris Canavan is Director, Global Policy Development, at Soros Fund Management, where he works on a variety of initiatives for the firm’s founder. Before that Chris worked for Goldman Sachs, serving in several capacities during his 13 years at the firm, including Chief Risk Officer of Goldman Sachs Bank USA, credit trader in the commodities […]
Dr. Joseph South

Joseph South, Director of the Office of Educational Technology, has extensive experience establishing and scaling educational technology solutions in startup, corporate, non-profit, and higher education settings. He was most recently Senior Director at K12 Inc where he performed double duty as a strategic consultant on higher education initiatives while directing K-12 curriculum development offices in […]
H.E. Han Seung-Soo

Dr. Han Seung-soo is a Member of the Republic of Korea’s National Assembly, to which he was first elected in 1988. Dr. Han has served in many areas of public life including, most recently, as Minister of Foreign Affairs and Trade from March 2001 to February 2002. From 1996 to 1997, he was Deputy Prime […]
Sheryl Sculley

Sheryl Sculley began serving as City Manager of San Antonio, Texas 10 years ago in November 2005. With 40 years in city management, Sculley is the Chief Executive Officer of the municipal corporation of 12,000 employees, an annual operating and capital budget of $2.4 billion, and a city population of 1.4 million residents. San Antonio […]
Dr. Todd Rose

Todd Rose is the director of the Mind, Brain, and Education program at the Harvard Graduate School of Education, where he leads theLaboratory for the Science of the Individual. The Lab’s flagship project is the Individual Mastery Project, also at the Harvard School of Education, a long-term study investigating the development of individual excellence and […]
Dr. Stephen Nimer

Dr. Nimer is an expert in treating leukemia and lymphoma. A hematologist, molecular biologist, and bone marrow transplant physician, Dr. Nimer is currently the Director of the Sylvester Comprehensive Cancer Center at the University of Miami, Florida. Dr. Nimer was at Memorial Sloan-Kettering Cancer Center in New York for nearly 20 years, where he held […]
Frederick Kempe

Fred Kempe is the president and chief executive officer of the Atlantic Council. Under his leadership since 2007, the Council has achieved historic, industry-leading growth in size and influence, expanding its work through regional centers spanning the globe and through centers focused on topics ranging from international security and energy to global trade and next […]
Dr. Daniel Keller

Dr. Daniel Keller holds a solid background in biology and biomedical research with academic journalism training. With a PhD in immunology and microbiology, Dr. Keller has reported on just about all medical specialty areas from major conferences worldwide, earning both print and broadcast journalism awards. Typical audiences are health care professionals. Dr. Keller has also produced radio series […]
H.E. Vuk Jeremić

Vuk Jeremić was elected President of the sixty-seventh session of the United Nations General Assembly on 8 June 2012. At the time of his election, he was serving as Minister of Foreign Affairs of the Repubic of Serbia, an office he held starting on 15 May 2007. Throughout his five years as Foreign Minister, Mr. […]
Dr. Paul Howard

Paul Howard is a senior fellow at the Manhattan Institute and director of health policy. He is a contributor to The Apothecary, the Forbes blog on health care policy and entitlement reform, and a regular columnist for The Morning Consult. Howard has written on a wide variety of medical-policy issues, including FDA reform, biopharmaceutical innovation, […]